Wunderz Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Cochin, Kerala, India, established in 2007.
2007 Cochin, Kerala, India Active
Last Updated:
Access Report
About Wunderz Pharmaceuticals Private Limited

Wunderz Pharmaceuticals Private Limited, a active private limited company, was established on 18 May 2007 in Cochin, Kerala, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U24232KL2007PTC020811. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹2.00 M and a paid-up capital of ₹1.69 M.

It upholds a compliant status. Employing 23 professional, Its leadership includes Gogi George (Director), Rias Chamakkalayil Abdulkareem (Director), Rajesh Kochupurayil Madanan Pillai (Managing Director). Past directors included Gogi George, Twinkle Mathew, Rias Chamakkalayil Abdulkareem. It holds ₹0.50 M open charges and ₹4.50 M settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at T.C.28/1171-C, Indira Nagar Kochu Kadavanthra, Cochin, Kerala, 682020.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232KL2007PTC020811

  • Registration Number

    020811

  • Incorporation Date

    18 May 2007

  • Authorized Capital

    ₹2.00 M

  • Paid-Up Capital

    ₹1.69 M

  • ROC Code

    Roc Ernakulam

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.00 M
  • Paid Up Capital ₹ 1.69 M
  • Company Age 18 Year, 10 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 0.50 M
  • Satisfied Charges ₹ 4.50 M
  • Revenue Growth **** 9.09%
  • Profit Growth **** 5.31%
  • Ebitda **** 11.22%
  • Net Worth 8.55%
  • Total Assets **** 16.69%
Company report

Wunderz Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Wunderz Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Wunderz Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Gogi George Director 03 May 2018 Current
Rias Chamakkalayil Abdulkareem Director 03 May 2018 Current
Rajesh Kochupurayil Madanan Pillai Managing Director 18 May 2007 Current
Pradeep Radhakrishnannair Director 29 Mar 2016 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 29 Sep 2018 Past
Pramod Abcsdd Whole-Time Director 05 Jul 2016 Past
Pramod Abcsdd Additional Director 29 Sep 2018 Past
Pramod Abcsdd Whole-Time Director 14 Jul 2016 Past
Pramod Abcsdd Director 15 Nov 2009 Past
Pramod Abcsdd Director 18 Dec 2018 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Wunderz Pharmaceuticals.

Wunderz Pharmaceuticals Private Limited, for the financial year ended 2015, experienced modest growth in revenue, with a 9.09% increase. The company also saw a slight improvement in profitability, with a 5.31% increase in profit. The company's net worth moved up by a moderate rise of 8.55%.

Wunderz Pharmaceuticals revenue growth over time
Wunderz Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 9.09%
*******
*******
*******
*******
Revenue from Operations
*******
 9.06%
*******
*******
*******
*******
Total Assets
*******
 16.69%
*******
*******
*******
*******
Profit or Loss
*******
 5.31%
*******
*******
*******
*******
Net Worth
*******
 8.55%
*******
*******
*******
*******
EBITDA
*******
 11.22%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Wunderz Pharmaceuticals?

In 2017, Wunderz Pharmaceuticals had a promoter holding of 97.18% and a public holding of 2.82%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹500,000.00

Satisfied Charges

₹4,500,000.00

Charges Breakdown by Lending Institutions
  • State Bank Of India : 0.05 Cr
Latest Charge Details
Date Lender Amount Status
31 Mar 2014 State Bank Of India ₹0.50 M Open
17 May 2011 The Karur Vysya Bank ₹3.00 M Satisfied
14 Oct 2009 The Dhanalakshmi Bank Ltd ₹1.00 M Satisfied
18 Aug 2008 The Dhanalakshmi Bank Limited ₹0.50 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Wunderz Pharmaceuticals?

Wunderz Pharmaceuticals has a workforce of 23 employees as of Mar 21, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Wunderz Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wunderz Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Wunderz Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Wunderz Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Wunderz Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ernakulam. was completed.

  • Director Appointment

    Gogi George was appointed as a Director was appointed as a Director on 03 May 2018 & has been associated with this company since 7 years 10 months . was recorded as a recent event.

  • Director Appointment

    Rias Chamakkalayil Abdulkareem was appointed as a Director was appointed as a Director on 03 May 2018 & has been associated with this company since 7 years 10 months . was recorded as a recent event.

  • Charges

    A charge with State Bank Of India of Rs. 0.50 M registered on 31 Mar 2014 with Charge ID 10495546 was modified on 06 Dec 2017. was recorded as a recent event.

  • Director Appointment

    Pradeep Radhakrishnannair was appointed as a Director was appointed as a Director on 29 Mar 2016 & has been associated with this company since 9 years 11 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Wunderz Pharmaceuticals Private Limited?

The CIN of Wunderz Pharmaceuticals Private Limited is U24232KL2007PTC020811.

Where is Wunderz Pharmaceuticals Private Limited headquartered?

Wunderz Pharmaceuticals Private Limited is headquartered at T.C.28/1171-C, Indira Nagar Kochu Kadavanthra, Cochin, Kerala, 682020.

When was Wunderz Pharmaceuticals Private Limited incorporated?

Wunderz Pharmaceuticals Private Limited was incorporated on 18 May 2007.

Who are the current directors of Wunderz Pharmaceuticals Private Limited?

The current directors of Wunderz Pharmaceuticals Private Limited are

What is the primary industry of Wunderz Pharmaceuticals Private Limited?

The primary industry of Wunderz Pharmaceuticals Private Limited is Pharma.

Is Wunderz Pharmaceuticals Private Limited a listed company?

Wunderz Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Wunderz Pharmaceuticals Private Limited?

The authorized capital of Wunderz Pharmaceuticals Private Limited is ₹2.00 M, and the paid-up capital is ₹1.69 M.

What is the compliance status of Wunderz Pharmaceuticals Private Limited?

The compliance status of Wunderz Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available